Clinical Trial Update: Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of ruxolitinib with radiation and temozolomide for grade III gliomas and glioblastoma; the study is active but not curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Ruxolitinib (ruxolitinib)
• Temodar (Temozolomide)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Glioma, Glioblastoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING